In the week following the announcement of this acquisition, Sanro Health, Inc. is reported to have made an investment in ...
The lesion characteristics of patients with geographic atrophy (GA) were found to affect the lesion growth rate, with ...
The software includes scattergrams comparing attempted vs achieved corrections, which can be used to refine surgical ...
To celebrate Ophthalmology Times' 50th anniversary, we asked leading experts what the practice would look like today had ...
Oluwatosin U. Smith, MD, reflects on early experiences caring for pediatric patients with complex glaucoma and how evolving ...
Iron dysregulation contributes to oxidative stress, inflammation, and ferroptosis, driving retinal degeneration in dry AMD ...
ONL Therapeutics announced the first patient has been randomized in its phase 2 GALAXY ( NCT06659445) trial evaluating ...
Andrew G. Lee, MD, was joined by Drew Carey, MD, for a live recording of the Ophthalmology Times “NeuroOp Guru” during the ...
The BIM-IOL system showed a 42% reduction in mean IOP and improved visual acuity, with no serious adverse events linked to ...
David Eichenbaum, MD, FASRS, recalls an early-career case managing bilateral diabetic macular edema with frequent ...
Broadwood Partners, STAAR's largest shareholder, opposes the Alcon merger, citing board conflicts and rushed decision-making.
To explore the implications of this latest approval and what it means for US surgeons and their patients, the Eye Care ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback